54Indexed trials
Market Rank #44 · Evidence Tier A
Slovakia
Neuroscience Intelligence
Slovakia neuroscience intelligence: 54 indexed trials, 12 institutions, research score 28.03.
7Recruiting
12Research institutions
28.0Research score
Evidence profile
40Sponsors
15Disease areas
0Institution works
0Institution citations
Evidence signals
Research score 28.0 · Data confidence 100.00 · Evidence 28.0
Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.
Leading disease areas
epilepsy10trials
parkinsons9trials
alzheimers8trials
schizophrenia6trials
multiple_sclerosis4trials
depression4trials
migraine_headache3trials
other_neurology2trials
bipolar_disorder2trials
pain_neuropathy1trials
Leading indexed sponsors
Sumitomo Pharma America, Inc.4trials
Boehringer Ingelheim4trials
Pfizer3trials
Hoffmann-La Roche3trials
UCB Biopharma SRL2trials
UCB Pharma2trials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2trials
Newron Pharmaceuticals SPA2trials
Biohaven Therapeutics Ltd.1trials
Bial - Portela C S.A.1trials